Cargando…

Progressive vision loss as the initial symptom of Prostate Cancer

Althought it may vary between countries, since the prostate specific antigen screening era, metastasic prostate cancer at diagnosis accounts for approximately 10% of cases. Intracranial dural metastases are uncommon, but when present they may lead to an increase in intracranial pressure that can sub...

Descripción completa

Detalles Bibliográficos
Autores principales: Davila-Legorreta, Ernesto, Rodenas-Gil, Erick Alejandro, Navarro-Ruesga, Iñigo, Santa Maria-Orozco, Francisco Javier, Cantellano-Orozco, Mauricio, Pacheco-Gahbler, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073208/
https://www.ncbi.nlm.nih.gov/pubmed/35530535
http://dx.doi.org/10.1016/j.eucr.2022.102000
_version_ 1784701235273662464
author Davila-Legorreta, Ernesto
Rodenas-Gil, Erick Alejandro
Navarro-Ruesga, Iñigo
Santa Maria-Orozco, Francisco Javier
Cantellano-Orozco, Mauricio
Pacheco-Gahbler, Carlos
author_facet Davila-Legorreta, Ernesto
Rodenas-Gil, Erick Alejandro
Navarro-Ruesga, Iñigo
Santa Maria-Orozco, Francisco Javier
Cantellano-Orozco, Mauricio
Pacheco-Gahbler, Carlos
author_sort Davila-Legorreta, Ernesto
collection PubMed
description Althought it may vary between countries, since the prostate specific antigen screening era, metastasic prostate cancer at diagnosis accounts for approximately 10% of cases. Intracranial dural metastases are uncommon, but when present they may lead to an increase in intracranial pressure that can subsequently damage intracranial structures, such as the cranial nerves. Prolonged intracranial hypertension can cause optic nerve ischemia, leading to progressive and irreversible vision loss if untreated, hence the importance of anamnesis, complete physical examination, and clinical suspicion.
format Online
Article
Text
id pubmed-9073208
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90732082022-05-07 Progressive vision loss as the initial symptom of Prostate Cancer Davila-Legorreta, Ernesto Rodenas-Gil, Erick Alejandro Navarro-Ruesga, Iñigo Santa Maria-Orozco, Francisco Javier Cantellano-Orozco, Mauricio Pacheco-Gahbler, Carlos Urol Case Rep Oncology Althought it may vary between countries, since the prostate specific antigen screening era, metastasic prostate cancer at diagnosis accounts for approximately 10% of cases. Intracranial dural metastases are uncommon, but when present they may lead to an increase in intracranial pressure that can subsequently damage intracranial structures, such as the cranial nerves. Prolonged intracranial hypertension can cause optic nerve ischemia, leading to progressive and irreversible vision loss if untreated, hence the importance of anamnesis, complete physical examination, and clinical suspicion. Elsevier 2022-01-13 /pmc/articles/PMC9073208/ /pubmed/35530535 http://dx.doi.org/10.1016/j.eucr.2022.102000 Text en © 2022 Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Oncology
Davila-Legorreta, Ernesto
Rodenas-Gil, Erick Alejandro
Navarro-Ruesga, Iñigo
Santa Maria-Orozco, Francisco Javier
Cantellano-Orozco, Mauricio
Pacheco-Gahbler, Carlos
Progressive vision loss as the initial symptom of Prostate Cancer
title Progressive vision loss as the initial symptom of Prostate Cancer
title_full Progressive vision loss as the initial symptom of Prostate Cancer
title_fullStr Progressive vision loss as the initial symptom of Prostate Cancer
title_full_unstemmed Progressive vision loss as the initial symptom of Prostate Cancer
title_short Progressive vision loss as the initial symptom of Prostate Cancer
title_sort progressive vision loss as the initial symptom of prostate cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073208/
https://www.ncbi.nlm.nih.gov/pubmed/35530535
http://dx.doi.org/10.1016/j.eucr.2022.102000
work_keys_str_mv AT davilalegorretaernesto progressivevisionlossastheinitialsymptomofprostatecancer
AT rodenasgilerickalejandro progressivevisionlossastheinitialsymptomofprostatecancer
AT navarroruesgainigo progressivevisionlossastheinitialsymptomofprostatecancer
AT santamariaorozcofranciscojavier progressivevisionlossastheinitialsymptomofprostatecancer
AT cantellanoorozcomauricio progressivevisionlossastheinitialsymptomofprostatecancer
AT pachecogahblercarlos progressivevisionlossastheinitialsymptomofprostatecancer